Publication | Closed Access

Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease

Combinatorial Chemistryβ-Amyloid AggregationAlzheimer's DiseaseBiochemistryMedicinePharmacological AgentAlzheimer ’Novel Dual-acting Thiazole-pyridiniumsPharmacologyPharmaceutical ChemistryDrug Discovery